Medtronic
NYSE MDT · Galway, Ireland
Works in Cardiovascular · Genetic & rare · Musculoskeletal · Neurology · Renal & urogenital · Women's health
Medtronic is a clinical trial sponsor based in Galway, Ireland, listed as NYSE MDT. It has 13 active clinical trials with 206,902 planned participants, across 6 therapeutic areas. Since 2021 it has completed 11 trials and stopped 2 early.
Trial track record · since 2021
Financials · NYSE MDT
Pipeline · 13 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Medtronic
Medtronic is lead sponsor of 13 active clinical trials on ClinicalTrials.gov, with 206,902 planned participants, in Cardiovascular, Genetic & rare, Musculoskeletal, Neurology and other areas. Since 2021 it has completed 11 trials and stopped 2 early.
Medtronic is based in Galway, Ireland and is listed as NYSE MDT. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Medtronic; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-09.
Approve Suite is not affiliated with Medtronic.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.